Targeting RPRD1B overcomes chemoresistance in gastric cancer by suppressing the TOPBP1-mediated DNA damage repair pathway.

Sheng J, Li J, Cao C, Liu X, He C, Fei M, Wu B, Li X, Hu C, Liu S, Lv Y

DOI: 10.1007/s13402-026-01227-0
Published: 2026 Aug 2
Container: Cellular oncology (Dordrecht, Netherlands)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13402-026-01227-0,
  title = {Targeting RPRD1B overcomes chemoresistance in gastric cancer by suppressing the TOPBP1-mediated DNA damage repair pathway.},
  author = {Sheng J and Li J and Cao C and Liu X and He C and Fei M and Wu B and Li X and Hu C and Liu S and Lv Y},
  year = {2026},
  journal = {Cellular oncology (Dordrecht, Netherlands)},
  doi = {10.1007/s13402-026-01227-0},
  url = {https://doi.org/10.1007/s13402-026-01227-0}
}

RIS

TY  - JOUR
TI  - Targeting RPRD1B overcomes chemoresistance in gastric cancer by suppressing the TOPBP1-mediated DNA damage repair pathway.
AU  - Sheng J
AU  - Li J
AU  - Cao C
AU  - Liu X
AU  - He C
AU  - Fei M
AU  - Wu B
AU  - Li X
AU  - Hu C
AU  - Liu S
AU  - Lv Y
PY  - 2026
JO  - Cellular oncology (Dordrecht, Netherlands)
DO  - 10.1007/s13402-026-01227-0
UR  - https://doi.org/10.1007/s13402-026-01227-0
ER  -

APA

J, S., J, L., C, C., X, L., C, H., M, F., B, W., X, L., C, H., S, L., & Y, L. (2026). Targeting RPRD1B overcomes chemoresistance in gastric cancer by suppressing the TOPBP1-mediated DNA damage repair pathway.. Cellular oncology (Dordrecht, Netherlands). https://doi.org/10.1007/s13402-026-01227-0

Source records

pubmed · retrieved 2026-09-26T23:56:29.737Z